http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0461499-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04
filingDate 1991-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886fe29e6263a9b9be4bbb630183a25a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e389fe4a2bd84d8675721aaf4b826ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748f028baf5b66259a567bae03284c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_222973f90e92238a792304ffe4d519ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e231992ffcbbf954908abded0a411c44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cd4905cfb53f00f5700c80017b767b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b41da33c2559573fced6ce889c0ef75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908a4bd53033dc5bb5c01e38314265c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c610e6917780ca39bbdf698dfc42588e
publicationDate 1991-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0461499-A2
titleOfInvention Use of efomycins A, E and G as antiinflammatory agents
abstract The present invention relates to the use of the known natural substances efomycin A, E and G of the general formula in which R₁ and R₂ have the meaning given in the description, for the treatment of acute and chronic inflammation, in particular their use as a medicament in myocardial infarction therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291515-B1
priorityDate 1990-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0197360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0236894-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60152418-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6444206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396388
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426109511
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227462312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8411
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863271
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775

Total number of triples: 58.